Pharmacovigilance usually involves the complex processes of medical monitoring and patient safety. Challenges include the monitoring of medication, and the difficulties inherent in collecting information on patients’ adverse drug reactions.
Clinixir recognizes pharmacovigilance is crucial for the pharmaceutical industry. We carefully conduct pharmacovigilance programs to make sure that each studied drug is safe, effective and ready for market exposure. Our team will guide you through the entire process, helping you gain public trust as you market your new drugs or medical devices.
Since adverse effects may occur unexpectedly in the later stages, the process of pharmacovigilance covers all three different phases of the drug development lifecycle: the pre-market period, development period and post-market period.
Clinixir provides a rigorous pharmacovigilance service that meets international standards. Our team closely monitors and analyzes adverse drug reactions in a regulatory-compliant manner, even after the drug is distributed for real-world usage. This depth of commitment helps to ensure safe and effective drug use for patients.
Some drugs and medications may have harmful side effects; therefore, any adverse events that occur should be identified as soon as possible to minimize potential harm to patients.
We work tirelessly to enhance data collection and medical monitoring quality. Our trials and surveillance procedures scrupulously follow standard regulations, with all clinical research and medical reports reviewed by our experts. Furthermore, our professionals are capable of identifying and analyzing all Adverse Drug Reactions (ADRs), Serious Adverse Events (SAEs) and Suspected Unexpected Serious Adverse Reactions (SUSARs) to ensure the highest standards of patient safety.